Long-term cardiovascular outcomes after anthracycline and trastuzumab therapy in HER2-positive breast cancer: 5-year follow-up from the EMBRACE-MRI study
30 August 2026 (12:45 - 13:00)
Organised by: 
Abstract
About the speaker
University Health Network of Toronto, Toronto (Canada)
3 More presentations in this session
Doctor S. Johansen (Copenhagen, DK)
Access the full session
The Event
ESC Congress 2026
30 August 2026
12:45 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
